T Scientific티사이언티픽
057680 · KOSDAQ · ₩057680 · 티사이언티픽
₩1,368▼ ₩42 (2.98%)End-of-day · Oct 30, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩36B | ₩43B | ₩27B | ₩8.7B | ₩10B |
| Cost of sales | ₩25B | ₩33B | ₩19B | ₩4.5B | ₩5.8B |
| Gross profit | ₩11B | ₩10B | ₩8.1B | ₩4.2B | ₩4.3B |
| Operating income | ₩264M | −₩9.8B | −₩5.6B | −₩2.5B | ₩1B |
| Net income | −₩1.6B | ₩2.3B | −₩49B | −₩12B | −₩3.2B |
| Net income to shareholders | −₩1.3B | ₩2.2B | −₩45B | −₩11B | −₩3.2B |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | ₩201B | ₩163B | ₩174B | ₩263B | ₩296B |
| Current assets | ₩29B | ₩23B | ₩31B | ₩46B | ₩31B |
| Cash and equivalents | ₩12B | ₩3.1B | ₩8.5B | ₩11B | ₩4.3B |
| Total liabilities | ₩32B | ₩24B | ₩43B | ₩82B | ₩74B |
| Current liabilities | ₩16B | ₩23B | ₩41B | ₩45B | ₩32B |
| Borrowings | ₩5.3B | ₩1.3B | ₩13B | ₩37B | ₩17B |
| Total equity | ₩169B | ₩139B | ₩131B | ₩181B | ₩222B |
| Shareholders' equity | ₩170B | ₩140B | ₩131B | ₩178B | ₩222B |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | ₩721M | −₩13B | −₩11B | −₩2.3B | −₩42M |
| Capital spending | ₩82M | ₩96M | ₩198M | ₩411M | ₩82M |
| Free cash flow | ₩638M | −₩13B | −₩11B | −₩2.7B | −₩124M |
Consolidated where available. Amounts in won.
Also known as: T Scientific / 티사이언티픽 / 057680 / KRX:057680
Source: KRX statistical information